- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Current Price: $177.93
RBC Capital thinks that Regeneron is at an attractive entry point due to its belief that the market is undervaluing the near-term market opportunity of Regeneron’s Eylea treatment along with its broader pipeline. The firm recommends purchasing the stock on pullbacks and it keeps its Outperform rating on the stock.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.